Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: January 23, 2008
Last updated: September 26, 2015
Last verified: August 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)